Newsletters – GliMR2.0 – COST Action CA18206

Menu

Menu

Newsflash

January 29, 2024

January 2024

Newsletter #16

November 6, 2023

November 2023

Newsflash

September 25, 2023

September 2023

Newsflash

September 5, 2023

September 2023

Newsletter #15

February 2023

Newsflash

February 23, 2023

Newsflash Feb 2023 - ITC for ISMRM

Newsletter #14

February 3, 2023

February 2023

Newsflash

January 23, 2023

Newsflash January 2023

Newsletter #13

July 2022

Newsflash

Newsflash July 2022

Newsflash

Newsflash July 2022

Newsflash

May 2022

Newsflash

April 2022

Newsletter #12

April 2022

Newsflash

March 2022

Newsflash

March 2022

Newsflash

March 2022

Newsflash

March 2022

Newsflash

Februari 2022

Newsletter #11

February 1, 2022

January 2022

Newsflash

December 7, 2021

December 2021

Newsflash

December 7, 2021

November 2021

Newsletter #10

December 7, 2021

January 2022

Newsflash

December 7, 2021

October 2021

Newsflash

December 7, 2021

September 2021

Newsletter #9

September 8, 2021

September 2021

Newsflash

September 8, 2021

August 2021

Newsflash

September 8, 2021

August 2021

Newsflash

June 2021

Newsletter #8

May 2021

Newsletter #7

March 2021

Newsflash

January 2021

Newsflash

January 2021

Newsflash

December 2020

Newsletter #6

November 2020

Newsletter #5

September 2020

Newsletter #4

July 2020

Newsletter #3

May 2020

Newsflash

March 2020

Newsletter #2

March 2020

Newsflash

February 2020

Newsflash

January 2020

Newsletter #1

December 2019

Follow Us

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST Action CA18206

This COST Action aims to build a pan-European and multidisciplinary network of international experts in glioma research, patient organisations, data scientists, and MR imaging scientists by uniting the glioma imaging community within Europe and progressing the development and application of advanced MR imaging for improved decision making in diagnosis, patient monitoring, and assessment of treatment response in clinical trials and clinical practice.

Action Details

Memorandum of Understanding (MoU)
Start Date: 12 September 2019
End Date: 11 September 2023
CSO approval date: 4 June 2019
Email: glimrca18206@erasmusmc.nl

Subscribe Newsletter

By subscribing you agree with our Privacy Policy.

© 2020 GliMR2.0 COST Action CA18206 • Privacy Policy

Design by Boutik